ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005